Compounds > amikacin
Page last updated: 2024-08-23

amikacin and Liver Dysfunction

amikacin has been researched along with Liver Dysfunction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Anser, H; Jahan, N; Mehboob, M; Mehboob, S; Mehjabeen, -; Owais, F; Perveen, S; Saleem, DM; Tariq Rafi, SM1
Alba, L; Behta, M; Clock, SA; Della-Latta, P; Furuya, EY; Jenkins, SG; Jia, H; Kubin, CJ; Oliveira, AP; Patel, SJ; Rhee, K; Saiman, L; Schuetz, AN; Weisenberg, SA; Whittier, S; Zhou, JJ1
Bancroff, G; Bucke, W; Ehlers, S; Fortmann, L; Hahn, H; Hänsch, H; Leitzke, S; Müller, R; Smith, D1

Other Studies

3 other study(ies) available for amikacin and Liver Dysfunction

ArticleYear
Hepatotoxicity induced by chronic suppurative otitis media in rats and effects of ceftazidime and amikacin on it.
    Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:3(Special)

    Topics: Alanine Transaminase; Alkaline Phosphatase; Amikacin; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Bilirubin; Ceftazidime; Chronic Disease; gamma-Glutamyltransferase; Liver; Liver Diseases; Otitis Media, Suppurative; Rats; Treatment Outcome

2021
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.
    American journal of infection control, 2014, Volume: 42, Issue:6

    Topics: Acinetobacter Infections; Adolescent; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Immunocompromised Host; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors

2014
Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1996, Volume: 284, Issue:2-3

    Topics: Amikacin; Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Granuloma; Injections, Intravenous; Liposomes; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Mycobacterium avium; Time Factors; Tuberculosis

1996